COVID-19 and children with Down syndrome: is there any real reason to worry? Two case reports with severe course

[1]  Joseph M. Campos,et al.  544. Severe COVID-19 in Children and Young Adults in the Washington DC Metropolitan Region , 2020 .

[2]  K. Wilson,et al.  COVID-19 and multisystem inflammatory syndrome in children and adolescents , 2020, The Lancet Infectious Diseases.

[3]  M. Callea,et al.  Trisomy 21 and the coronavirus disease 2019 (COVID-19). , 2020, Archivos argentinos de pediatria.

[4]  Allen Cheng,et al.  Update on the COVID‐19‐associated inflammatory syndrome in children and adolescents; paediatric inflammatory multisystem syndrome‐temporally associated with SARS‐CoV‐2 , 2020, Journal of paediatrics and child health.

[5]  L. Henderson,et al.  American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1 , 2020, Arthritis & rheumatology.

[6]  W. Chung,et al.  SARS-CoV-2 Infection in Patients with Down Syndrome, Congenital Heart Disease, and Pulmonary Hypertension: Is Down Syndrome a Risk Factor? , 2020, The Journal of Pediatrics.

[7]  M. Dierssen,et al.  Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19 , 2020, Scientific Reports.

[8]  Nicole M. Bouvier,et al.  COVID-19 Hospitalization is More Frequent and Severe in Down Syndrome , 2020, medRxiv.

[9]  H. D. De Cauwer,et al.  Are patients with Down syndrome vulnerable to life-threatening COVID-19? , 2020, Acta Neurologica Belgica.

[10]  Angelo Mazza,et al.  An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study , 2020, The Lancet.

[11]  R. DeBiasi,et al.  Severe Coronavirus Disease-2019 in Children and Young Adults in the Washington, DC, Metropolitan Region , 2020, The Journal of Pediatrics.

[12]  M. Cabana,et al.  Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City , 2020, The Journal of Pediatrics.

[13]  M. Priestley,et al.  Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. , 2020, JAMA pediatrics.

[14]  P. Theocharis,et al.  Hyperinflammatory shock in children during COVID-19 pandemic , 2020, The Lancet.

[15]  M. Lenge,et al.  Children with Covid-19 in Pediatric Emergency Departments in Italy , 2020, The New England journal of medicine.

[16]  J. Espinosa.  Down Syndrome and COVID-19: A Perfect Storm? , 2020, Cell Reports Medicine.

[17]  F. Hickey,et al.  Routine Screening for Celiac Disease in Children with Down Syndrome Improves Case Finding. , 2020, Journal of pediatric gastroenterology and nutrition.

[18]  J. Espinosa,et al.  JAK1 inhibition blocks lethal sterile immune responses: implications for COVID-19 therapy , 2020, bioRxiv.

[19]  Qiurong Ruan,et al.  Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China , 2020, Intensive Care Medicine.

[20]  J. Espinosa,et al.  Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity , 2019, Proceedings of the National Academy of Sciences.

[21]  C. Carty,et al.  The prevalence of obesity in children and young people with Down syndrome , 2018, Journal of applied research in intellectual disabilities : JARID.

[22]  P. Salice,et al.  Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase , 2018, Italian Journal of Pediatrics.

[23]  S. Lafranchi,et al.  Characterization of Thyroid Abnormalities in a Large Cohort of Children with Down Syndrome
 , 2017, Hormone Research in Paediatrics.

[24]  M. Yeager,et al.  What people with Down Syndrome can teach us about cardiopulmonary disease , 2017, European Respiratory Review.

[25]  V. Srikanth,et al.  Risk of Major Cardiovascular Events in People with Down Syndrome , 2015, PloS one.

[26]  Z. Memish,et al.  Middle East Respiratory Syndrome Coronavirus Disease in Children , 2014, The Pediatric infectious disease journal.

[27]  Z. Memish,et al.  Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study , 2013, The Lancet Infectious Diseases.

[28]  Thao Nguyen,et al.  The interferons and their receptors—distribution and regulation , 2012, Immunology and cell biology.

[29]  U. Parashar,et al.  Severe Acute Respiratory Syndrome in Children , 2007, The Pediatric infectious disease journal.

[30]  J. Journeycake,et al.  Down Syndrome as an Independent Risk Factor for Thrombosis in Children. , 2006 .

[31]  M. Kurrer,et al.  Disseminated and sustained HIV-infection in CD34+ cord blood cell transplanted Rag2-/-gc-/- mice , 2006, Retrovirology.

[32]  C L Marcus,et al.  Obstructive sleep apnea in children with Down syndrome. , 1991, Pediatrics.

[33]  E. Korn,et al.  Altered cellular immune functions in patients with Down's syndrome. , 1981, American journal of diseases of children.

[34]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..